Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and clinical endpoints in haemodialysis patients with type 2 diabetes mellitus: results from the 4D Study | Zendy

Barbara Kollerits | Zendy; Christiane Drechsler | Zendy; Vera Krane | Zendy; Claudia Lamina | Zendy; Winfried März | Zendy; Hans Dieplinger | Zendy; Eberhard Ritz | Zendy; Christoph Wanner | Zendy; Florian Kronenberg | Zendy

Open Access

Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and clinical endpoints in haemodialysis patients with type 2 diabetes mellitus: results from the 4D Study

Author(s) -

Barbara Kollerits,

Christiane Drechsler,

Vera Krane,

Claudia Lamina,

Winfried März,

Hans Dieplinger,

Eberhard Ritz,

Christoph Wanner,

Florian Kronenberg

Publication year - 2016

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfv428

Subject(s) - medicine , hazard ratio , lipoprotein(a) , diabetes mellitus , proportional hazards model , dialysis , population , gastroenterology , apolipoprotein b , lipoprotein , prospective cohort study , type 2 diabetes , endocrinology , cholesterol , confidence interval , environmental health

High lipoprotein(a) [Lp(a)] concentrations and low molecular weight (LMW) apolipoprotein(a) [apo(a)] isoforms are associated with cardiovascular disease and mortality in the general population. We examined the association of both with all-cause mortality and cardiovascular endpoints in haemodialysis patients with diabetes mellitus.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research